No shortage on file

LORAZEPAM INJECTION, USP

FRESENIUS KABI CANADA LTD

Quick answers

Is there a shortage of LORAZEPAM INJECTION, USP in Canada?

No. There is no current shortage of LORAZEPAM INJECTION, USP 4MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file2 products · 1 same form & route

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

LORAZEPAM INJECTION USP

SANDOZ CANADA INCORPORATED

4MG · DIN 02243278

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

PRO-LORAZEPAM

PRO DOC LIMITEE

1MG · DIN 00655651

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DIN

02550962

Strength

4MG

Dosage Form

Solution

Route

Intravenous Intramuscular

Active Ingredient

LORAZEPAM

See all LORAZEPAM products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

No shortage or discontinuation reports on file for this product.

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02267659